- £753.49m
- £951.49m
- £1.46bn
- 51
- 47
- 98
- 75
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,142 | 1,201 | 1,222 | 1,421 | 1,462 |
Cost of Revenue | |||||
Gross Profit | 71.9 | 77.6 | 72.6 | — | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,087 | 1,149 | 1,169 | 1,360 | 1,415 |
Operating Profit | 54.6 | 52 | 53 | 61.4 | 46.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 48.6 | 43.8 | 48.4 | 54.8 | 38.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 42.8 | 38.5 | 41.3 | 47.9 | 33.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 42.8 | 38.5 | 41.3 | 47.9 | 33.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 42.8 | 38.5 | 41.3 | 47.9 | 33.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.363 | 0.466 | 0.252 | 0.411 | 0.646 |
Dividends per Share |